Arthritis by the Numbers

Arthritis by the Numbers

Arthritis By The Numbers - 1 - TABLE OF CONTENTS Introduction ......................................................................................................... 5 Section 1: General Arthritis Facts .......................................................................... 7 o Human and Economic Burdens ......................................................................................9 - Economic Burdens......................................................................................................9 - Employment Impact and Medical Cost Burden .......................................................10 •Osteoporosis ............................................................................................. 12 o Prevalence ......................................................................................................................12 o Human and Economic Burdens ......................................................................................13 - Health Burdens ...........................................................................................................14 - Economic Burdens......................................................................................................14 Section 2: Osteoarthritis (OA) ............................................................................... 16 •# OA Patient Story – Kathy Geller.......................................................................... 17 •Osteoarthritis (OA) o Prevalence ......................................................................................................................................19 - US General Population ............................................................................................................19 - Global Prevalence ....................................................................................................................19 o Human and Economic Burdens ....................................................................................................20 - Health Burdens .........................................................................................................................20 - Knee, Hip and Shoulder OA Burden ......................................................................................21 - Economic Burdens ....................................................................................................................22 - Global Burden ..........................................................................................................................23 o Military OA ....................................................................................................................................26 - Prevalence in the Military .........................................................................................................26 - Human and Economic Burdeny ................................................................................................26 - Global Burden for Military and Other Tactical Athletesy .......................................................26 Section 3: Autoimmune and Inflammatory Arthritis .............................................. 28 •# RA Patient Story – Eileen Schneider .................................................................... 30 •Rheumatoid Arthritis (RA) ..................................................................................... 31 o Prevalence .....................................................................................................................................31 o Human and Economic Burdens ....................................................................................................31 - Health Burdens .........................................................................................................................31 - Work/Employment Impact ......................................................................................................32 - Medical/Cost Burdens ............................................................................................................32 •# SLE Patient Story – Liz Morass .................................................................................................................33 •Systemic Lupus Erythematosus (SLE or Lupus) ........................................................ 34 o Prevalence .....................................................................................................................................34 o Human and Economic Burdens ....................................................................................................35 - Comorbidities and Health Burdens .........................................................................................35 - Pregnancy Impact .....................................................................................................................37 - Work/Employment Impact ......................................................................................................37 - Medical/Cost Burdens ............................................................................................................38 Arthritis Foundation •Sjögren’s Syndrome .............................................................................................. 40 o Prevalence (Primary Sjögren’s Syndrome) ..................................................................................40 o Comorbidities (Secondary Sjögren’s Syndrome) ........................................................................40 o Human and Economic Burdens ....................................................................................................41 - Health Burdens .........................................................................................................................41 - Work/Employment Impact ......................................................................................................45 - Medical/Cost Burdens ............................................................................................................45 •Adult-onset Scleroderma ....................................................................................... 46 o Prevalence ......................................................................................................................................46 o Human and Economic Burdens ....................................................................................................46 - Health Burdens .........................................................................................................................46 - Economic Burdens ....................................................................................................................47 •Spondyloarthritis (SpA) ......................................................................................... 48 o General Prevalence ......................................................................................................................48 •Ankylosing Spondyloarthritis (AS) ........................................................................ 48 o Prevalence .....................................................................................................................................48 o Human and Economic Burdens ....................................................................................................48 - Health Burdens ..............................................................................................................................48 - Economic Burdens ....................................................................................................................49 •# PsA Patient Story – Karen Lomas ........................................................................ 50 •Psoriatic Arthritis (PsA) .......................................................................................... 51 o Prevalence ......................................................................................................................................51 o Human and Economic Burdens ....................................................................................................51 - Health Burdens .........................................................................................................................51 - Economic Burdens ....................................................................................................................52 Section 4: Juvenile Idiopathic Arthritis (JIA) and Other Childhood Rheumatic Diseases ............................................. 54 •Common Forms of Juvenile Arthritis (JA) ................................................................ 55 •# JIA/Juvenile-onset Fibromyalgia Patient Story – Soler Family ............................ 56 •Juvenile Idiopathic Arthritis (JIA) ........................................................................... 58 o Prevalence .....................................................................................................................................58 o Human and Economic Burdens ....................................................................................................59 - Health Burdens .........................................................................................................................59 - Mental Health Impact ..............................................................................................................60 - School and Social Impact ........................................................................................................60

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    102 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us